A novel approach of longitudinal adverse event evaluation in oncology clinical trials: the Toxicity over Time (ToxT) analysis of clinical trials N9741 and 979254 (Alliance)

por Thanarajasingam, Gita, Atherton, Pamela J., Novotny, Paul J., Loprinzi, Charles L., Sloan, Jeff A., Grothey, Axel
Publicado 2016

Patient-reported quality-of-life outcomes in relation to provider-assessed adverse events during head and neck radiotherapy

por Niska, Joshua R., Thorpe, Cameron S., Halyard, Michele Y., Tan, Angelina D., Atherton, Pamela J., Dueck, Amylou C., Patel, Samir H., Sloan, Jeff A.
Publicado 2020

Nivolumab in patients with relapsed or refractory peripheral T-cell lymphoma: modest activity and cases of hyperprogression

por Bennani, N Nora, Kim, Hyo Jin, Pederson, Levi D, Atherton, Pamela J, Micallef, Ivana N, Thanarajasingam, Gita, Nowakowski, Grzegorz S, Witzig, Thomas, Feldman, Andrew L, Ansell, Stephen M
Publicado 2022